Liquidia Technologies LQDA 深 沪
已收盘 10-02 16:00:00 美东时间
28.64
+0.650
+2.32%
华盛通- 最 高29.1794
- 今 开26.69
- 成交量 840.32万股
- 最 低 26.31
- 昨 收 27.99
- 总市值 25.64亿
- 52周最高 93.61
- 市盈率 静 --
- 换手率 9.39%
- 52周最低 21.94
- 委 比 -20.00%
- 总股本 8950.89万
- 历史最高 93.61
- 量 比 0.87
- 振 幅 10.25%
- 历史最低 2.25
- 每 手 1
- 风险率 20.13%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Liquidia’s LIQ861 Transition Study Adds Fresh Momentum to the PAH Investment Story
Liquidia Technologies ($LQDA) announced an update on their ongoing clinical stu...
10-03 00:31
美股大行评级 | 潜在涨幅1654.39%！Ascendiant Capital上调NRX Pharmaceuticals(NRXP)目标价至50美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从49美元升至50美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从24美元升至25美元
10-02 08:33
Liquidia Stock Extends Slide Following US Court Ruling in Patent Dispute
Shares of Liquidia Corp (NASDAQ:LQDA) are sliding Thursday morning, extending a sell-off triggered by an adverse federal court patent ruling in its ongoing legal dispute with rival United Therapeutics. Here’s what investors need to know. Liquidia stock is feeling bearish pressure. Why is LQDA stock ...
10-02 00:03
This ExxonMobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Julian Harrison downgraded Liquidia Corporation (NASDAQ:LQDA) from Buy to Neutral. L...
10-01 23:56
Progress Software, Nft And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures falling around 200 points on Thursday. Shares of Progress Software Corp (NASDAQ:PRGS) fell sharply in pre-market trading after the company reported third-quarter financial results. Progress Software reported fiscal third-quarter revenu...
10-01 20:01
BTIG Downgrades Liquidia to Neutral
BTIG analyst Julian Harrison downgrades Liquidia (NASDAQ:LQDA) from Buy to Neutral.
10-01 18:01
Needham Maintains Buy on Liquidia, Lowers Price Target to $72
Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $110 to $72.
10-01 17:15
Why is Liquidia (LQDA) Stock Trending After Hours?
Liquidia Corp. (NASDAQ:LQDA) shares are trending on Wednesday night. Shares of the North Carolina-based biopharmaceutical company edged 0.13% higher to $30.30 in after-hours trading on Wednesday. In the regular session, LQDA closed at $30.26, down 57.19%, according to Benzinga Pro data. The stock ex...
10-01 11:29
Liquidia plunges amid court ruling in United Therapeutics patent fight
Liquidia Corp. (LQDA) quickly dropped 25% after a court ruling in its ongoing patent dispute with United Therapeutics (UTHR) over its Yutrepia drug. United Therapeutics rose 6.2%. The court said Liqui...
09-30 23:42
Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent
A U.S. District Court ruled that two claims of United Therapeutics' '327 patent related to Liquidia's YUTREPIA (treprostinil) inhalation powder are valid and infringed. The remaining four claims were found invalid. Liquidia disagrees with the decision and plans to pursue appellate options, including removing PH-ILD from YUTREPIA's label. Potential remedies could include label changes or market restrictions. YUTREPIA, approved for PAH and PH-ILD, ...
09-30 17:20
